|
Re: Resverlogix Invites Collaborations for use of Apabetalone in Trials and Studies to Combat the Spread of COVID-19 Based on New Research
|
3
|
Resverlogix Corp.
|
Mar 23, 2020 09:56AM
|
|
Re: Resverlogix Expands Phase 2b Clinical Trial for COVID-19
|
1
|
Resverlogix Corp.
|
Feb 17, 2022 07:33AM
|
|
Re: Resverlogix Expands Phase 2b Clinical Trial for COVID-19
|
2
|
Resverlogix Corp.
|
Feb 17, 2022 07:59AM
|
|
Re: RESVERLOGIX CORP.CODE OF BUSINESS CONDUCT AND ETHICS
|
1
|
Resverlogix Corp.
|
Sep 12, 2019 03:36PM
|
|
Re: RESVERLOGIX CORP. Annual And Special Meeting: December 22, 2020
|
3
|
Resverlogix Corp.
|
Nov 25, 2020 09:16AM
|
|
Re: RESVERLOGIX CORP. Annual And Special Meeting: December 22, 2020
|
2
|
Resverlogix Corp.
|
Nov 25, 2020 09:41AM
|
|
Re: RESVERLOGIX CORP. Annual And Special Meeting: December 22, 2020
|
1
|
Resverlogix Corp.
|
Nov 25, 2020 11:48AM
|
|
Re: RESVERLOGIX CORP WTS 2021
|
1
|
Resverlogix Corp.
|
May 11, 2021 09:14AM
|
|
Re: RESVERLOGIX CORP WTS 2021
|
2
|
Resverlogix Corp.
|
May 11, 2021 02:50PM
|
|
Re: RESVERLOGIX CORP WTS 2021
|
1
|
Resverlogix Corp.
|
May 11, 2021 03:10PM
|
|
Re: RESVERLOGIX CORP WTS 2021
|
1
|
Resverlogix Corp.
|
May 10, 2021 11:16AM
|
|
Re: Resverlogix Confirms Interim Filings on SEDAR
|
1
|
Resverlogix Corp.
|
Oct 03, 2020 02:58PM
|
|
Re: Resverlogix Confirms Interim Filings on SEDAR
|
4
|
Resverlogix Corp.
|
Oct 04, 2020 06:26AM
|
|
Re: Resverlogix Confirms Interim Filings on SEDAR
|
1
|
Resverlogix Corp.
|
Oct 05, 2020 05:39PM
|
|
Re: Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions
|
3
|
Resverlogix Corp.
|
Sep 28, 2022 04:41PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
1
|
Resverlogix Corp.
|
Mar 24, 2020 09:54AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
1
|
Resverlogix Corp.
|
Mar 24, 2020 04:10PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
1
|
Resverlogix Corp.
|
Mar 24, 2020 04:37PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
7
|
Resverlogix Corp.
|
Mar 27, 2020 10:19AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 27, 2020 10:58AM
|
